Lilly to present new data across its dermatology portfolio with 21 presentations at Fall Clinical 2026, in pursuit of advancing care for chronic skin conditions

Summary

Eli Lilly will present 21 presentations on its dermatology portfolio at Fall Clinical 2026, including new EBGLYSS data demonstrating durable disease control, less frequent maintenance dosing, and reduced topical treatment use in moderate-to-severe atopic dermatitis patients.